More about

Lupus

News
January 04, 2023
2 min read
Save

Black, Hispanic patients with lupus have worse COVID-19 outcomes than white patients

Black, Hispanic patients with lupus have worse COVID-19 outcomes than white patients

Black and Hispanic patients with systemic lupus erythematous demonstrate more severe COVID-19 outcomes than white patients, according to data published in Arthritis Care & Research.

News
December 21, 2022
2 min read
Save

COVID-19 pandemic reduced access to optimal lupus care, providers report

COVID-19 pandemic reduced access to optimal lupus care, providers report

Health care professionals around the world are reporting that the COVID-19 pandemic has prevented patients with systemic lupus erythematosus from receiving optimal care, resulting in increased risk for organ damage, according to a survey.

News
December 12, 2022
2 min read
Save

Patients with chronic sleep deprivation at higher risk for lupus

Patients with chronic sleep deprivation at higher risk for lupus

Individuals with chronic sleep deprivation demonstrate a higher risk for developing systemic lupus erythematosus, with stronger effects in those with depression and bodily pain, according to data published in Arthritis Care & Research.

News
December 09, 2022
5 min read
Save

‘Huge surprise’: CAR-T cell therapy leads to remission in severe lupus

‘Huge surprise’: CAR-T cell therapy leads to remission in severe lupus

Five patients with systemic lupus erythematosus achieved remission after receiving chimeric antigen receptor T-cell therapy, a result that could change the face of treatment for autoimmune conditions, according to researchers.

News
November 22, 2022
1 min read
Save

Women with lupus demonstrate low HPV vaccination rates, high infection rates

Women with lupus demonstrate low HPV vaccination rates, high infection rates

PHILADELPHIA — Among women with systemic lupus erythematosus, just 3.7% are vaccinated for HPV, while nearly 30% demonstrate HPV infection, according to data presented at ACR Convergence 2022.

News
November 17, 2022
2 min read
Save

TYK2 inhibitor deucravacitinib ‘shows promise’ as novel lupus therapy

TYK2 inhibitor deucravacitinib ‘shows promise’ as novel lupus therapy

PHILADELPHIA — Phase 2 findings for the tyrosine kinase 2 inhibitor deucravacitinib yielded encouraging results through 48 weeks in patients with systemic lupus erythematosus, according to data presented at ACR Convergence 2022.

News
November 17, 2022
1 min read
Save

High copays lower odds of ‘optimal adherence’ to lupus treatment

High copays lower odds of ‘optimal adherence’ to lupus treatment

PHILADELPHIA — Among patients with lupus, those with higher copays are more likely to demonstrate poor treatment adherence, according to data presented at ACR Convergence 2022.

News
November 16, 2022
1 min read
Save

Most screenings for fetal congenital heart block do not occur by recommended time

Most screenings for fetal congenital heart block do not occur by recommended time

PHILADELPHIA – In anti-Ro/La-positive pregnancies, most fetal echocardiography screenings for congenital heart block fail to occur by the recommended time, according to data presented at ACR Convergence 2022.

News
November 15, 2022
2 min read
Save

Belimumab effective for cutaneous lupus erythematosus, regardless of SLE, after 20 weeks

Belimumab effective for cutaneous lupus erythematosus, regardless of SLE, after 20 weeks

PHILADELPHIA — Belimumab demonstrated a strong clinical response and significantly reduced flare risk for patients with cutaneous lupus erythematosus, with or without systemic lupus erythematosus, after 20 weeks, said a presenter here.

News
November 15, 2022
1 min read
Save

Risk factors may predict progression of discoid to severe systemic lupus erythematosus

Risk factors may predict progression of discoid to severe systemic lupus erythematosus

Diagnosis of discoid lupus erythematosus in patients aged younger than 25 years may predict the onset of severe systemic lupus erythematosus, according to study findings.

View more